Flexible processing characteristics! A polymer that is also used as a material for new medical devices.
Poly-p-dioxanone (PDO) is obtained by ring-opening polymerization of p-dioxanone as a monomer. It is primarily processed into biodegradable sutures and is also used as a raw material for new medical devices, allowing for processing into various shapes due to its flexible processing characteristics. Our BioDegmer is produced in facilities compliant with ISO 13485 and can be processed into a wide variety of shapes, being used in a broad range of applications in the medical field. 【Features】 ■ Primarily processed into biodegradable sutures ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: crystalline, insoluble (except for low molecular weight variants), flexibility *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Example)】 Test Items: Standards ■ Polymer Identification: Must match the NMR spectrum of standard PDO ■ Inherent Viscosity: ηinh = 1.5 − 1.8 (dL/g) [0.8 g/dL HFIP, 30 ℃] ■ Melting Point (Tm): Tm = 100 − 110 (℃) ■ MFR: MFR(240, 10) = 3.0 − 9.0 (g/10min) ■ Particle Size: Must not pass through a sieve with an opening of 500 µm *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Applications】 ■ Threads (single thread, braided cord, mesh): Suturing threads, stents, artificial dura mater reinforcement materials, adhesion prevention membrane reinforcement materials, scaffolds ■ Films: Adhesion prevention membranes, artificial dura mater *For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Kyoto University Institute for Advanced Medical Research. Focusing on the field of medical polymers (macromolecules), we are engaged in two promising growth businesses: the "BioDegmer" business and the new products business, as well as research and development aimed at providing innovative solutions in the medical field. Under the management philosophy of "contributing to the health of people around the world by working on the development of better biomaterial products and providing innovative solutions in the medical field," we support the improvement of technologies in the next generation of regenerative medicine and the healthy well-being of people in three areas.